AI assistant
Episurf — Regulatory Filings 2016
Nov 9, 2016
3157_rns_2016-11-09_69314386-5780-4352-b1b9-9b696d984b7e.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
Company Announcement November 9, 2016
Episurf Medical AB to present at Stora Aktiedagen, held in Gothenburg on November 14
Episurf Medical AB will present at Stora Aktiedagen, an investor conference held in Gothenburg (Svenska Mässan) on November 14. The company will be represented by CFO Pål Ryfors.
For full program and registration, see link. (http://www.aktiespararna.se/storaaktiedagen)
For more information, please contact: Pål Ryfors, CFO, Episurf Medical Tel: +46 709 62 36 69 Email: [email protected]
About Episurf Medical
Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalized treatment alternatives. Episurf Medical's Episealer® personalized implants and Epiguide® surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical's μiFidelity® system enables implants to be cost-efficiently tailored to each individual's unique injury for the optimal fit and minimal intervention. Episurf Medical's head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company's website: www.episurf.com.
This information is information that Episurf Medical AB is obliged to make public pursuant to the Financial Instruments Trading Act.